ClinicalTrials.Veeva

Menu

Prehabilitation for Patients Awaiting Liver Transplantation (Prehab preLT)

McGill University logo

McGill University

Status

Enrolling

Conditions

Liver Transplantation
Cirrhosis, Liver
Frailty

Treatments

Behavioral: Prehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT05237583
2021-7646

Details and patient eligibility

About

This study will assess the feasibility, safety and effectiveness of a structured prehabilitation program combining exercise training, nutritional optimization and psychological support for patients with cirrhosis awaiting liver transplantation.

Full description

Due to their chronic liver disease, patients with cirrhosis awaiting liver transplantation develop low muscle mass, poor nutritional status and decreased reserves putting them at high risk of postoperative complications, prolonged hospital stay, and failed discharge home after liver transplantation. Prehabilitation aims to optimize a patient before they undergo a major surgery. These programs combine exercise training, with nutritional optimization and psychological support. Together, these contribute to improve their muscle mass, tolerance to exercise, and nutritional status. The current study will assess whether an individualized and structured prehabilitation program combining supervised exercise training, nutritional optimization and psychological support will benefit patients with cirrhosis awaiting liver transplantation.

Enrollment

25 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age above 18 years
  • Diagnosis of cirrhosis, based on a combination of clinical, laboratory, imaging, or histology
  • Active on the liver transplant waiting list of the MUHC

Exclusion criteria

  • Biological Model for End Stage Liver Disease >20
  • Hepatic decompensation within the last month
  • High risk varices not on primary or secondary prevention
  • Recurrent large volume paracentesis
  • Persistent hepatic encephalopathy
  • Platelets <20,000/µL, or hemoglobin <80g/L
  • Altered hemodynamics
  • Significant heart disease
  • Awaiting combined organ transplantation
  • Awaiting repeat liver transplantation
  • Condition limiting mobilization and/or exercise, or recurrent falls

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

Prehabilitation
Experimental group
Description:
Multimodal prehabilitation program
Treatment:
Behavioral: Prehabilitation

Trial contacts and locations

1

Loading...

Central trial contact

Amine Benmassaoud, MD; Olivia Geraci

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems